The Effect of Morphine on Prasugrel Absorption in STEMI Patients
NCT01536964 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2022-06-14
Summary
Heart Attacks are a major cause of death in this country. When patients have a heart attack, they are treated with anti-clotting drugs, one of which is a drug called Prasugrel. It is important that Prasugrel starts to work as quickly as possible following a heart attack. As many patients who have a heart attack experience excruciating pain, they are often given morphine (a strong painkiller) by the Ambulance crew. We think that morphine may affect how Prasugrel is absorbed from the stomach and may delay how quickly it starts to work. We intend to study the effect of morphine on the absorption of Prasugrel.
Conditions
Interventions
- DRUG
-
morphine
2.5mg of morphine will be given post Prasugrel administration with a further 2.5mg 5 minutes later
- DRUG
-
saline
2.5ml of saline will be given post Prasugrel followed by a further 2.5ml as a comparator for the morphine
Sponsors & Collaborators
-
National Institute for Health Research, United Kingdom
collaborator OTHER_GOV -
Sheffield Teaching Hospitals NHS Foundation Trust
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-04-30
- Primary Completion
- 2013-03-31
- Completion
- 2013-03-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Early Mineralocorticoid Receptor Antagonist Treatment to Reduce Myocardial Infarct Size
NCT01882179 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Ischaemic-Reperfusion and Remote Ischaemic Preconditioning in Man - A Bradykinin Dependent Pathway
NCT00965393 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness of Intra-coronary Nitrite in Acute Myocardial Infarction
NCT01584453 ·Status: COMPLETED ·Phase: PHASE2
-
Sodium Thiosulfate to Preserve Cardiac Function in STEMI
NCT02899364 ·Status: UNKNOWN ·Phase: PHASE2
-
Nitrites in Acute Myocardial Infarction
NCT01388504 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Stellate Ganglion Morphine Infiltration on Myocardial I/R Injury
NCT07023679 ·Status: RECRUITING ·Phase: NA
-
Intravenous Streptokinase in Acute Myocardial Infarction
NCT00000507 ·Status: COMPLETED ·Phase: PHASE3
-
Prognosis and Antiplatelet Strategies for Patients With PCI and High Bleeding Risk:A Study Protocol
NCT05369442 ·Status: RECRUITING
-
Concomitant Milrinone and Esmolol Treatment in Patients with Acute Myocardial Infarction
NCT02098629 ·Status: COMPLETED ·Phase: PHASE2
-
Nitric Oxide in Myocardial Infarction Size
NCT00568061 ·Status: TERMINATED ·Phase: PHASE2
-
Facilitation Through Aggrastat By drOpping or Shortening Infusion Line in Patients With ST-segment Elevation Myocardial Infarction Compared to or on Top of PRasugrel Loading dOse
NCT01336348 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety on Prouk for STEMI Patients in China
NCT02367976 ·Status: UNKNOWN ·Phase: PHASE3
-
Optical Coherence Tomography-Guided PCI With Single-Antiplatelet Therapy
NCT04766437 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Opioids on P2Y12 Receptor Inhibition in Patients With ST-Elevation Myocardial Infarction Who Are Pre-treated With Crushed Ticagrelor
NCT03400267 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Morphine Treatment on Platelet Inhibition in Acute Myocardial Infarction
NCT02627950 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized Clinical Trial of Non-Surgical Reperfusion of the Coronary Arteries
NCT00000503 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Efficacy and SAfety of Intravenous Infusion of Nicorandil During Primary Percutaneous Coronary Intervention
NCT04665648 ·Status: COMPLETED ·Phase: PHASE4
-
Nitroprusside for Prevention of no-Reflow in Primary Angioplasty
NCT00128791 ·Status: TERMINATED ·Phase: PHASE4
-
Myocardial Infarction Triage and Intervention Project (MITI)
NCT00000468 ·Status: COMPLETED ·Phase: PHASE3
-
Very Early PCSK9 Inhibition for Acute Myocardial Infarction
NCT07208006 ·Status: RECRUITING ·Phase: NA
-
Efficacy Study of Combined Prasugrel and Bivalirudin Versus Clopidogrel and Heparin in Myocardial Infarction
NCT00976092 ·Status: UNKNOWN ·Phase: PHASE4
-
Pharmacogenetic Approach to Anti-platelet Therapy for the Treatment of ST-segment Elevation Myocardial Infarction (STEMI)
NCT01452139 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Nicorandil for the Patients of Acute ST Segment Elevation Myocardial Infarction
NCT02435797 ·Status: UNKNOWN ·Phase: PHASE4
-
Cangrelor in ST-Elevation Myocardial Infarction to Decrease Infarct Size
NCT03043274 ·Status: TERMINATED ·Phase: PHASE4
-
Heart Attack Blood Oxygen Therapy Trial
NCT06662890 ·Status: RECRUITING ·Phase: NA